Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus
Clinical trial NCT05966480 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05966480
- Sponsor
- Alumis Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-26
- Primary completion
- 2026-06-23
- Enrollment
- 408
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.